Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$NTLA Q4 '24 Earnings Results & Recap
Intellia's Q4'24 results showed EPS of -$1.27 (beating expectations of -$1.34), and revenue of $12.87M (beating expectations of $7.25M). Management expressed confidence in clinical trial progress, exceeding enrollment projections in the ATTR cardiomyopathy study and advancing the HAE Phase 3 trial. The company also highlighted a strong balance sheet and plans for future commercial launches.12
